跳至主要内容
临床试验/NCT05169762
NCT05169762招募中不适用

Feminizing Treatment in Transgender Women and Non-binary Persons BODY IDENTITY CLINIC - ESTROGEN

Odense University Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
coronary plaque formation

研究概览

简要总结

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.

详细描述

Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years,

Outcomes:

Non-calcified and calcified plaque formation by contras coronary CT angiograms Heartfunction by ekko Cardiovaskular risk markers, f. eks. bp Markers of cardiovascular risk in blood and urine

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • assigned male at birth and eligeble for gender affirming feminizing treatment

排除标准

  • 未提供

结局指标

主要结局

coronary plaque formation

时间窗: 1 year

mm3

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marianne Andersen

Clinical professor

Odense University Hospital

研究点 (1)

Loading locations...

相似试验

Feminizing Treatment in Transgender Women and... | 临床试验